4:02 PM ET
8-K
Capital Raise
ADARx Pharmaceuticals Capital Raise of $536M
ADARx Pharmaceuticals closed its initial public offering (IPO) of 26,250,000 shares and a concurrent private placement of 5,255,542 shares to AbbVie Inc., both priced at $17.00 per share. The combined transactions generated approximately $535.6 million in gross proceeds, with AbbVie acquiring a 4.9% stake in the company.
- Value
- $536M
- Counterparty
- AbbVie Inc.